Stonepine Capital Management, LLC Xeris Biopharma Holdings, Inc. Transaction History
Stonepine Capital Management, LLC
- $103 Billion
- Q1 2025
A detailed history of Stonepine Capital Management, LLC transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Stonepine Capital Management, LLC holds 102,265 shares of XERS stock, worth $472,464. This represents 0.55% of its overall portfolio holdings.
Number of Shares
102,265
Previous 182,317
43.91%
Holding current value
$472,464
Previous $618 Million
9.16%
% of portfolio
0.55%
Previous 0.5%
Shares
12 transactions
Others Institutions Holding XERS
# of Institutions
204Shares Held
84.7MCall Options Held
132KPut Options Held
69.4K-
Black Rock Inc. New York, NY10.3MShares$47.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.11MShares$37.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.29MShares$19.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.41MShares$15.7 Million0.0% of portfolio
-
State Street Corp Boston, MA3.33MShares$15.4 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $628M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...